This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated PAT up 684% on 17% revenue growth
OAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 4.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Q2 FY27 (quarter ended 30 Sep 2026) revenue was Rs 31,819.59 lakh, up 17.3% from Rs 27,133.27 lakh in the year-earlier quarter; PAT was Rs 578.80 lakh versus Rs 73.84 lakh, up 684%. EBITDA margin before other income, interest, depreciation and tax rose to 7.9% from 6.4%. Standalone Q2 PAT was Rs 1,023.63 lakh. Half-year consolidated operating cash flow was negative Rs 1,580.92 lakh.
Profit jump may support sentiment, but negative operating cash flow and Rs 44,298 lakh of borrowings keep leverage and cash strain in view.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹318.2 Cr | ₹271.3 Cr | +17.3% |
| Operating profit | ₹8.83 Cr | −₹0.28 Cr | turned positive |
| Profit after tax | ₹5.79 Cr | ₹0.74 Cr | +683.9% |
| EBITDA margin | 7.9% | 6.4% | +1.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.